Recession-proof stocks are the key to keeping your portfolio above water in times of economic uncertainty.

This behavioral healthcare conglomerate is not only considered recession-proof, but its rapidly growing expansion plan should peak anyones interest.

$40 billion is the annual revenue of treatment centers just in the United States and the industry is seeing incredible momentum — right now. Thus, investing in substance abuse treatment can be both profitable and an effective macroeconomic hedge.

So why THIS treatment conglomerate?

• A low-cost and high-speed, proven expansion plan
• Tighter borrowing costs have prevented others from executing similar acquisition ventures • Best in class, turnkey facilities and treatment programs
• In-network contracts to ensure continuous demand
• Careful selection of choice property acquisitions with upside core asset values

As the war with addiction wages on, the US health care system cannot keep up with the unfortunate, incredible demand for drug and alcohol abuse treatment. Small, well-run service companies are becoming monsters of the market.

Learn more about this company’s investment objective and forecasted upside. This is one roll up strategy you do not want to miss!